Appointment
Modus Therapeutics: Clinical development pro
She held other leadership positions in Clinical Operations; Project and Portfolio Management at Pfizer and also brings biotech and consulting experience to the CEO role, having worked in positions within U.S. biotech and management consulting. Donnelly received her Ph.D. from Yale University.
Donnelly took up her appointment on 25 April 2017, succeeding Christina Herder.